Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Black Grain Eumycetoma Causative Agents Identified by Molecular Method

By LabMedica International staff writers
Posted on 17 Dec 2014
A rapid, simple, and highly efficient molecular based method for identification of the causative agents of black grain eumycetoma has been introduced, aiming to improve diagnostics in endemic areas. More...


Accurate identification of mycetoma causative agent is a priority for treatment; however, current identification tools are far from being satisfactory for both reliable diagnosis and epidemiological investigations and the currently available molecular methods based on DNA sequencing though specific are extremely expensive.

Scientists at the University of Amsterdam (The Netherlands) collaborating with an international team, analyzed 62 isolates belonging to eight species causing black grain mycetoma: 32 Madurella mycetomatis, 1 M. fahalii , 3 M. pseudomycetomatis, 2 M. tropicana, 10 Trematosphaeria grisea, 6 Falciformispora senegalensis, 2 F. tompkinsii, and 6 Medicopsis romeroi. All strains were identified down to species level by sequencing of the ribosomal DNA (rDNA) internal transcribed spacer (ITS) region.

Rolling circle amplification (RCA) is a powerful diagnostic method based on detection of specific nucleic-acid sequences and enzymatic amplification of circularized oligonucleotide probes under isothermal conditions. The probes are linear oligonucleotides that contain two target-complementary sequences at their ends joined by linkers. The ends of the probe hybridize to the complementary target in juxtaposition and then ligate which allows the circularization of the probe. The circular structured molecule then amplifies with DNA polymerase that has strand displacement and progressive DNA synthesis activity resulting in series of repeats of the original circular template. After RCA, accumulated double stranded DNA was detected with an ultra violet (UV) transilluminator (Vilber Lourmat; Marne-la-Vallée, France).

RCA was used to identify 62 strains belonging to eight species causing human eumycetoma. Since black grain eumycetoma species are known to be phylogenetically distant, it was easy to find unique sites for their identification. The ribosomal ITS region was sufficient for identification of all species and showed no intraspecific variability within a set of 100 M. mycetomatis strains in the collection. With the isothermal RCA assay, the 62 isolates were successfully identified with 100% specificity and no cross reactivity or false results.

The authors concluded that RCA is extremely useful for specific identification of agents of mycetoma. Performance and rapid turnaround time features make the RCA suitable for quick and reliable diagnosis, which is an enormous improvement compared to the current phenotypic identification of mostly non-sporulating cultures. Future application of RCA could be the detection of agents DNA directly from clinical samples without requirement of culturing. The study was published on December 4, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of Amsterdam 
Vilber Lourmat 



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.